rethinkTHC Search
Menu
Study breakdown

A Case of Suicide Attempt Linked to Cognitive Decline From Polysubstance Use

Case ReportPreliminary evidence
The takeaway

A 30-year-old man who used cannabis, MDMA, and cocaine for three years developed cognitive deficits that led to professional and personal decline, depression, and a suicide attempt.

Read this if you're interested in the connection between substance use, cognitive function, and mental health.

Case study: cognitive decline from polysubstance use preceded a suicide attempt

What the researchers found

The authors described a 30-year-old man who used cannabis, MDMA (ecstasy), and cocaine for at least three years and subsequently developed significant cognitive and working memory deficits.

These cognitive problems led to increasing difficulties in his professional and personal life. As his functioning declined, he developed depressive symptoms including hopelessness and helplessness, which progressed to active suicidal ideation and ultimately a suicide attempt.

The authors proposed a causal chain: polysubstance use caused cognitive deficits, which caused functional decline, which caused depression, which caused suicidal behavior. They highlighted this pathway as an underrecognized mechanism linking substance use to suicide risk.

Why it matters

This case report proposed a specific mechanism by which substance use could lead to suicidality: through cognitive decline and functional impairment rather than through direct pharmacological effects on mood. This pathway may be underrecognized in clinical practice.

The numbers in context

One 30-year-old male patient. At least 3 years of polysubstance use (cannabis, MDMA, cocaine). Cognitive deficits in working memory and executive function. One suicide attempt documented.

How the study worked

This is a single case report describing one patient's clinical course. The authors assessed cognitive function, reviewed substance use history, and documented psychiatric symptoms and the suicide attempt.

What this study cannot tell us

A single case report cannot establish causation. The patient used multiple substances, making it impossible to attribute cognitive deficits to any single drug. Pre-existing vulnerabilities (cognitive, psychiatric) may have preceded substance use. No objective baseline cognitive testing was available.

How to read the evidence

This is a single case report, the weakest form of clinical evidence. It can generate hypotheses but cannot establish that the proposed causal chain applies broadly.

When this study was published

Published in 2007. The relationship between substance use, cognitive impairment, and suicidality has been explored in larger studies since.

The bigger picture

While a single case report cannot establish causation, the proposed pathway from cognitive decline to functional impairment to depression to suicidality represents an important clinical concept that subsequent research has continued to explore across different substance use populations.

Questions still open

  • How common is the pathway from substance-induced cognitive decline to suicidality? Can cognitive rehabilitation reduce suicide risk in this population?

Common questions

Was cannabis specifically responsible for the cognitive decline?
The patient used cannabis, MDMA, and cocaine together. The case report could not determine which substance or combination was most responsible for the cognitive deficits.
How common is this pattern?
A single case report cannot answer this. However, cognitive deficits from chronic substance use and their impact on functioning and mental health are documented across multiple study types.

Read the original research

High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.

Substance abuse, 28(1), 25-30

Citation

Pompili, Maurizio; Lester, David; Girardi, Paolo; Tatarelli, Roberto. (2007). High suicide risk after the development of cognitive and working memory deficits caused by cannabis, cocaine and ecstasy use.. Substance abuse, 28(1), 25-30. https://doi.org/10.1300/J465v28n01_04

Explore the wider topic